|
December 08
Eden Bioscience
announces Board of Directors' approval of plan of dissolution
and liquidation
February 07
Eden Bioscience
shareholders approve asset sale
December 06
Eden
Bioscience signs definitive agreement for sale of harpin technology and
substantially all assets related to agricultural and horticultural
markets to Plant Health Care - Company also
announces significant reduction in workforce; Dr. Rhett Atkins to resign
as CEO and President
August 06
Eden Bioscience
Corporation announces second quarter 2006 financial results
April 06
Eden Bioscience receives Nasdaq delisting
notice, plans reverse stock split
March 06
Soybean
cyst nematode infestations and damage reduced with N-Hibit seed
treatment from Eden Bioscience
NCGA/Eden
Bioscience ProAct Partnership on-farm trials average yield increase of 7
bushels per acre
July 05
Eden Bioscience announces
second quarter 2005 financial results
February 05
Eden Bioscience
receives U.S. EPA approval for use of ProAct, a new generation of
foliar-applied harpin protein designed to increase field crop yields
U.S. National Corn Growers
Association and Eden Bioscience team to
demonstrate harpin responses in corn
January 05
Eden Bioscience
debuts new cotton seed treatment product
July 03
EDEN
Bioscience announces second quarter 2003 financial results
May 03
EDEN Bioscience announces
cost reductions
April 03
EDEN Bioscience announces
first quarter 2003 financial results
February 02
EDEN Bioscience
announces fourth quarter and year end 2002 financial results
January 02
EDEN Bioscience announces
sublease of excess laboratory and office space
October 02
EDEN Bioscience announces
third quarter 2002 financial results
July 02
EDEN Bioscience announces
second quarter 2002 financial results
June 02
EDEN Bioscience appoints
industry veteran as CEO; Dr. Rhett R. Atkins brings 27 years of ag sales
and marketing experience
May 02
EDEN Bioscience announces
cost reductions
April 02
EDEN Bioscience announces
first quarter 2002 financial results
EDEN Bioscience's Messenger
receives unconditional EPA approval
January 02
EDEN Bioscience
announces fourth quarter and year end 2001 financial results
EDEN Bioscience receives
approval for use of Messenger in Germany
EDEN Bioscience receives
California registration for use of Messenger on tomatoes and peppers
November 01
EDEN Bioscience President
& CEO Jerry Butler resigns; Company appoints interim President; EDEN
also appoints
October 01
EDEN Bioscience
receives registration for use of Messenger in China
EDEN Bioscience
announces third quarter financial results
EDEN Bioscience
announces reduction in workforce
July 01
The Scotts Company and
EDEN Bioscience announce exclusive business agreement
EDEN Bioscience receives
registration for use of Messenger in Ecuador
EDEN Bioscience
announces second quarter financial results
June 01
U.S. company, EDEN
Bioscience, brings green technology to subsistence farmers
EDEN Bioscience selected
for Presidential Green Chemistry Challenge Award by U.S. Environmental
Protection Agency
EDEN Bioscience updates
second quarter 2001 financial outlook
April
01
EDEN Bioscience
announces first quarter financial results; Company receives
conditional approval for sale of Messenger in New York State
February
01
EDEN Bioscience
announces fourth quarter and year 2000 results
January
01
EDEN Bioscience
announces successful results in U. S. cotton field trials
April
00
New technology
from Eden Bioscience promises revolutionary benefits to world
agriculture, consumers
|
